|
|
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
Romain Guièze
,
Pauline Robbe
,
Ruth Clifford
,
Sophie De Guibert
,
Bruno Pereira
et al.
Journal articles
hal-01263113v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
Thorsten Braun
,
Sophie Cereja
,
Sylvie Chevret
,
Emmanuel Raffoux
,
Marie Beaumont
et al.
Journal articles
hal-01237097v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group
Lionel Adès
,
Xavier Thomas
,
Agnes Cuerci-Bres
,
Raffoux Emmanuel
,
Olivier Spertini
et al.
Blood, 2015, 126 (23), pp.451
Journal articles
hal-01300812v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.
Alexandre Janel
,
Frédérique Dubois-Galopin
,
Céline Bourgne
,
Juliette Berger
,
Karin Tarte
et al.
Journal articles
hal-01058950v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Emilie Reboursiere
,
Fabien Le Bras
,
Charles Herbaux
,
Emmanuel Gyan
,
Aline Clavert
et al.
Journal articles
hal-01475957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia
Caroline Dartigeas
,
Eric van den Neste
,
Christian Berthou
,
Hervé Maisonneuve
,
Stéphane Leprêtre
et al.
Journal articles
hal-01272930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets
Laurence De Leval
,
Marie Parrens
,
Fabien Le Bras
,
Jean-Philippe Jais
,
Virginie Fataccioli
et al.
Journal articles
hal-01301144v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial
Arnaud Pigneux
,
Christian Récher
,
Marie C. Bene
,
Julien Asselineau
,
Ariane C. Mineur
et al.
Blood, 2015, 126 (23)
Journal articles
hal-01295674v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|